The Hers website arranged on a laptop in New York, US, on Wednesday, Feb. 12, 2025. Gabby Jones | Bloomberg | Getty Images Hims & Hers Health announced Wednesday it will offer generic semaglutide in Canada as Novo Nordisk‘s patent on its branded drugs Ozempic and Wegovy is set to expire in January. “Canada is…
Check out the companies making headlines in midday trading: Tesla — Shares jumped more than 10% after Tesla rolled out its robotaxi service in Austin, Texas, over the weekend. Wedbush analyst Dan Ives said a ride in the taxi exceeded his expectations . However, some analysts were more reserved. Northern Trust — Shares rose 7%…
The Hims logo arranged on a smartphone in New York, US, on Wednesday, Feb. 12, 2025. Bloomberg | Bloomberg | Getty Images Hims & Hers Health announced Tuesday it will acquire European telehealth platform Zava in its push to expand globally. “We’re excited to take this moment to really accelerate both the European expansion, but…
Check out the companies making headlines in extended trading: Palantir Technologies — Shares dropped nearly 7% after the defense tech company reported first-quarter earnings that were in line with Wall Street’s expectations. Adjusted earnings of 13 cents per share came in line with the consensus estimate, per LSEG. Palantir reported $884 million in revenue, topping…
Check out the companies making headlines in midday trading: Spotify — Shares of the music streaming company lost 3.5% on the back of disappointing results. Spotify reported first-quarter operating income of 509 million euros, while analysts polled by FactSet expected 519.9 million euros. Spotify’s revenue of 4.2 billion euros was in line with estimates, while…
Check out the companies making headlines in midday trading: Spotify — Shares of the music streaming company lost 3.5% on the back of disappointing results. Spotify reported first-quarter operating income of 509 million euros, while analysts polled by FactSet expected 519.9 million euros. Spotify’s revenue of 4.2 billion euros was in line with estimates, while…
The “Wegovy” brand slimming syringe is sold in the Achat pharmacy in Mitte. The “Wegovy” slimming syringe has been available in Germany for a year. Jens Kalaene | Picture Alliance | Getty Images Novo Nordisk on Tuesday said it will offer its weight loss drug Wegovy through telehealth providers Hims & Hers Health, Ro and…
This week was supposed to mark the end of compounding pharmacies making copycat versions of Eli Lilly‘s weight-loss drug Zepbound and its diabetes drug Mounjaro. Online, it doesn’t look like much has changed. Popular websites like Amble, EllieMD, Willow and Mochi Health are all still advertising versions of tirzepatide, the active ingredient in Zepbound. Some,…
Check out the companies making headlines in midday trading: Tesla — Elon Musk’s electric vehicle company saw shares sliding another 5.2%, bringing month-to-date losses to around 23%. The sell-off came after Tesla’s China rival Zeekr said it is rolling out an advanced driver-assistance system for free . Meanwhile, RBC Capital Markets lowered its price target…
Check out the companies making headlines in midday trading. Solventum — Shares surged roughly 10% after the health-care company announced it would sell its purification and filtration business to Thermo Fisher Scientific for $4.1 billion. The transaction is expected to wrap up by the end of 2025. Sempra — The utility stock plunged 20%. Sempra…
